Synaps Dx is dedicated to transforming the diagnosis of Alzheimer’s disease (AD). Operating a CLIA-certified laboratory, we offer DISCERN™, the first commercially available test to accurately detect AD (>95%). info@synapsdx.com Granted Breakthrough Status by the FDA, DISCERN™ provides a convenient, accurate, minimally invasive diagnosis of Alzheimer’s disease. Through analysis of one (1) small in-office skin biopsy provided by a referring physician, SDx offers a reliable and accurate alternative to traditional diagnostic methods. Our diagnostic biomarkers have been confirmed by neuropathological validation (NIH “Gold Standard”).
| Website | https://www.synapsdx.com/ |
| Employees | 20 (12 on RocketReach) |
| Founded | 2016 |
| Address | 12441 Parklawn Dr 2A, Rockville, Maryland 20852, US |
| Industry | Biotechnology |
| Competitors | C2N Diagnostics, Quest Diagnostics, Neurotrack, Biogen, Roche, Genentech, Alector, Amgen, Lilly India, Eisai Co., Ltd. +34 more (view full list) |
Looking for a particular SYNAPS Dx employee's phone or email?
12 people are employed at SYNAPS Dx.
SYNAPS Dx is based in Rockville, Maryland.